CASE STUDY

Awareness Campaign for Rare Cancer Studies

Awareness Campaign for Rare Cancer Studies

Two studies testing the same study drug were seeking to recruit patients with rare cancer indications, both with very limited patient populations. Richter’s syndrome is a rare transformation that occurs in about 5-10% of patients with Chronic Lymphocytic Leukemia, and Diffuse Large B-Cell Lymphoma accounts for about 30% of newly diagnosed cases of Non-Hodgkin Lymphoma in the US.

 

ProNai_Wolverine_CoverPhoto_R1_V1[1].jpg

 

 

Related Content